TRNS Transcat, Inc.
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. It also provides calibration, repair, preventive maintenance, electrical safety inspection, and documentation and regulatory compliance services to hospital networks and healthcare facilities in the southeastern United States. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.…
Industry Peers
Specialty Business ServicesKey Statistics
About Transcat (NASDAQ: TRNS)
›
Transcat (NASDAQ: TRNS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Business Services industry, part of the Industrials sector, and reports about 1,413 employees.
The shares were at 92.97 USD on 20 November 2026, up 68.0% over 52 weeks. Its 52-week range is 50.23 USD to 112.44 USD: the price is 17.3% below the high and 85.1% above the low.
At a market capitalisation of 874.37M USD, it trades at 193.7 times trailing earnings and 39.7 times forward earnings. The median trailing P/E of its 20 largest Specialty Business Services peers is 28.9, a premium of 570% for TRNS.
Transcat reports return on equity of 1.8%, an operating margin of 5.0% and revenue up 18.0% year over year.
Its debt exceeds its cash by 145.19M USD, a debt-to-equity ratio of 0.44. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 110.80 USD is 19.2% above the current price. The next earnings report is expected on 2 February 2027.